http://www.acc.org/Feed?clinicalTopicID=c5ff91a9-f0f4-4291-84b8-6604ce7c4778 Clinical Topic Feed: Cardiac Surgery and Heart Failure en /Latest-in-Cardiology/Articles/2026/09/18/13/43/ACC-Quality-Summit-Abstract-Winners With a record-breaking number of abstract submissions, the quality improvement projects presented at ACC Quality Summit 2026 reflect an ongoing commitment to improve cardiovascular care through innovation, collaboration and quality. Read on for highlights from the top ePosters. 1789753380000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1788264540000 Articles and Stories /Latest-in-Cardiology/Articles/2026/08/10/13/07/eagles-eye-view-12aug2026 In this week’s View, Dr. Eagle looks at the wide variation in antithrombotic regimens after valve-in-valve transcatheter aortic valve replacement (TAVR). Next, he examines PARTNER-3, a 7-year study on TAVR versus surgical aortic valve replacement (SAVR) outcomes in low-risk patients. 1786537680000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/22/13/15/eagles-eye-view-22jul2026 In this week’s View, Dr. Eagle looks at age, body mass index (BMI), and cardiovascular outcomes after transcatheter aortic valve replacement (TAVR). 1784726220000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/15/14/19/eagles-eye-view-15jul2026 In this week’s View, Dr. Eagle looks at the feasibility of mechanical leaflet splitting in high-risk patients undergoing valve-in-valve transcatheter aortic valve replacement (TAVR). 1784125200000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026 In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM). 1782910140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/Genotype-Independently-Predicts-HF-Outcomes In patients with hypertrophic cardiomyopathy (HCM), genotype, peak VO2, log NT-proBNP and LVEF independently predict heart failure (HF) outcomes, and combining these measures identified patients at higher risk of HF-related death or transplant, according to a recent study published in JACC: Heart Failure. 1782228900000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1780315620000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026 In this week’s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment. 1779288780000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026 Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA... 1778607960000 Articles and Stories